These results imply that inadequate protein intake may contribute to NAFLD incidence in people with low genetic risk potentially via FGF21-pathway induction, while those with high genetic risk already have relatively elevated FGF21-pathway activity, regardless of protein intake level. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.